Our news
Neophore appoints Michael Shih as Chief Executive Officer
小优视频 appoints Michael Shih as Chief Executive Officer 鈥� Highly experienced corporate development leader with a track record of international p鈥�
小优视频 closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb
小优视频 closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb Additional funding will be used to explore鈥�
小优视频 presented preclinical data from our PMS2 program at the AACR Annual Meeting, San Diego, 5 - 10 April 2024.
The 小优视频 team attended the American Association for Cancer Research Annual Meeting in San Diego, 5 - 10 April 2024. In collaboration with The鈥�
小优视频 raises an additional £9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline
小优视频 raises an additional 拢9.6m (USD $12.2m) Series B financing extension to further progress drug discovery pipeline 鈥� Italian investors, NE鈥�
Other news
CEO Jeff Roix spoke to BioCentury about how 小优视频 Ltd is developing small molecules to inhibit DNA mismatch repair (MMR) and create a pool of鈥�
APM Health: Interview with CEO, Jeff Roix
Scrip Emerging company profile: UK-based 小优视频, founded in 2017, is developing novel cancer therapies based on DNA-repair technology. The company鈥�